Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase 4 Study of Two Intravenous Temsirolimus Regimens in Relapsed, Refractory Mantle Cell Lymphoma
2009-015498-11Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of temsirolimus in mantle cell lymphoma (MCL) (2 arms), sponsored by Pfizer. Primary endpoint: Progression-free survival (independent assessment). Started Jul 2010; status: completed.
02
Drugs
temsirolimus
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2009-015498-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015498-11.